Stroyakovskiy, D., Akhmadiyarova, Y., Iurchenkov, A., Savelov, N., Sekhniaidze, D., Shilo, P., Stoliarov, V., Danilova, A. (2026). Nivolumab plus ipilimumab with chemotherapy as first-line therapy for NSCLC: A single-center real-world experience.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20630